InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
27%
T+90 mean return
-8.7%
Across 22 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by CARREL MICHAEL H, Chairman & CEO. Officer active across 2 companies, notably AtriCure, Inc.. Cumulatively, 32 filings have been logged. History available since 30 June 2021. The latest transaction was filed on 8 August 2025 (Don). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations32 total
636 sharesCommon StockSEC:0001230584-26-000006:0
10,000 shares0Common StockSEC:0001230584-25-000003:0
4,000 shares0Common StockSEC:0001323885-25-000029:0
50,335 shares0Common StockSEC:0001323885-25-000021:0
17,861 shares@ US$71.00100.0% of flowCommon StockSEC:0001562180-24-007701:0
3,000 shares0Common StockSEC:0001323885-24-000108:0
707 shares@ US$19.3516.4% of flowCommon StockSEC:0001323885-24-000099:0
2,000 shares0Common StockSEC:0001323885-24-000044:0
50,854 shares0Common StockSEC:0001323885-24-000037:0
10,000 shares0Common StockSEC:0001323885-23-000115:0
500 shares0Common StockSEC:0001562180-23-006245:0
1,250 shares0Common StockSEC:0001323885-23-000101:0
557 shares@ US$38.1125.0% of flowCommon StockSEC:0001323885-23-000077:0
3,000 shares0Common StockSEC:0001562180-23-005531:0
1,000 shares0Common StockSEC:0001323885-23-000071:0
69,234 shares0Common StockSEC:0001323885-23-000032:0
6,000 shares0Common StockSEC:0001323885-22-000118:0
2,100 shares0Common StockSEC:0001562180-22-006262:0
350 shares@ US$34.7314.9% of flowCommon StockSEC:0001323885-22-000090:0
67,109 shares0Common StockSEC:0001323885-22-000025:0
510 shares0Common StockSEC:0001323885-22-000013:0
141 shares@ US$59.109.4% of flowCommon StockSEC:0001209191-22-000381
141 shares@ US$59.100.0005% mcap21.6% of flowCommon StockSEC:0001209191-22-000381:0
10,000 shares0Common StockSEC:0001209191-21-068766:0
10,000 shares0Common StockSEC:0001209191-21-068766
25 of 32 declarations
About CARREL MICHAEL H
Michael H. Carrel is President, CEO, and a Director at AtriCure, Inc. and Axonics, Inc. In these roles, he oversees the operations and strategy of the companies, which specialize in medical technologies. Mr. Carrel is responsible for strategic direction and operational management.
